AKT is a well-characterized candidate of phosphoinositide 3-kinase (PI3K) in PI3K/AKT/mTOR signaling pathway medicating cell survival responses in cancer [8], as well as a key point in PTEN/AKT/p53/cyclinD1 underlying tumorigenesis [9]. The gene discussed is AKT1; the disease is cancer.